The high expression of CD44 in tumor cells enables it as a well-characterized targeted receptor for breast and ovarian cancer stem cells, and CD44 can form complexes with hyaluronan (HA) which can trigger the endocytosis by tumor cells (Chen et al., 2017; Gautam et al., 2020). This evidence concerns the gene CD44 and ovarian carcinoma.